Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma
Open Access
- 25 June 2014
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2014, 1-6
Abstract
To clarify the role of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma (CCRCC), we measured the serum levels of soluble interleukin-2 receptor (sIL-2R), soluble B7-H3 (sB7-H3), and soluble cytotoxic T lymphocyte associated antigen-4 (sCTLA-4) in 70 CCRCC patients and 35 healthy controls. We investigated correlations between the serum levels of these soluble T cell regulatory molecules and the pathological grade, clinical stage, and prognosis of CCRCC. We also assessed the relations among each of these soluble molecules. As a result, the serum level of sIL-2R was significantly higher in CCRCC patients than in healthy controls (). In addition, elevation of serum sIL-2R was significantly correlated with the clinical stage (), and the survival of patients with high sIL-2R levels was shorter than that of patients with low sIL-2R levels (). Furthermore, the serum level of sB7-H3 was also significantly correlated with the clinical stage (), while the sIL-2R and sB7-H3 levels showed a positive correlation with each other (,). These results indicate that the serum level of sIL-2R reflects tumor progression in CCRCC patients. In addition, the possibility was suggested that the IL-2/IL-2R and B7-H3 pathways may be involved in the progression of CCRCC.
Keywords
This publication has 36 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Identification of a Soluble Form of B7-H1 That Retains Immunosuppressive Activity and Is Associated with Aggressive Renal Cell CarcinomaClinical Cancer Research, 2011
- Interleukin-2 Receptor Signaling: At the Interface between Tolerance and ImmunityImmunity, 2010
- Tumor Cell and Tumor Vasculature Expression of B7-H3 Predict Survival in Clear Cell Renal Cell CarcinomaClinical Cancer Research, 2008
- Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and HypophysitisJournal of Immunotherapy, 2007
- Soluble interleukin-2 receptor in stage I–III melanomaCytokine, 2006
- THE B7 FAMILY REVISITEDAnnual Review of Immunology, 2005
- The Significance of Soluble lnterleukin-2 Receptor in Monitoring Disease Relapse in Patients with Nasopharyngeal CancerJapanese Journal of Clinical Oncology, 1998
- The IL-2/IL-2 receptor system: A current overviewCell, 1993
- Cloning of the γ Chain of the Human IL-2 ReceptorScience, 1992